Positron Corporation: A Strategic Move in Nuclear Cardiology with Three NeuSight PET-CT 64 Slice Scanners

Positron Corporation (OTC: POSC), a leading molecular imaging medical device company, has recently secured an agreement for the rental of three NeuSight PET-CT 64 slice scanners to a prominent cardiovascular diagnostic, management, and treatment practice. This strategic move underscores Positron's commitment to advancing nuclear cardiology and driving the adoption of cardiac PET-CT imaging.

The NeuSight PET-CT 64 slice scanner, an innovative and cost-effective system, offers exceptional performance, advanced technology, and unmatched value. Its patient-centered design features a spacious 72 cm gantry for enhanced comfort and high-sensitivity acquisition technology that minimizes radiation exposure for both patients and technicians. With the smallest footprint and lightest weight among PET-CT systems, the NeuSight PET-CT offers superior imaging capabilities while optimizing space utilization in modern healthcare facilities.



The NeuSight PET-CT's advanced data acquisition and identification technology enable faster and more precise scans, improving diagnostic accuracy. Offering both anatomic and functional imaging, the system supports a wide range of molecular imaging applications, including heart, tumor, and brain studies. This versatility allows healthcare providers to utilize the system for various clinical studies, such as cardiology and oncology, making it an ideal solution for practices seeking enhanced diagnostic and disease management capabilities.

Positron's commitment to collaborating with leading cardiovascular practices plays an important role in the advancement of nuclear cardiology and reinforces its objective to drive the adoption of cardiac PET-CT imaging. By entering this agreement, Positron has demonstrated its ability to penetrate the market and attract high-profile customers, further solidifying its position as a leading provider of molecular imaging medical devices and clinical support services.

The rental of three NeuSight PET-CT 64 slice scanners to a leading cardiovascular practice is expected to have a positive impact on Positron's financial projections for the next fiscal year. The agreement generates recurring revenue through the rental program, ensuring accessibility to advanced imaging technology for customers. This strategic move also opens up new revenue streams and contributes to the company's financial growth.

In conclusion, Positron Corporation's agreement for the rental of three NeuSight PET-CT 64 slice scanners to a prominent cardiovascular practice highlights the company's commitment to advancing nuclear cardiology and driving the adoption of cardiac PET-CT imaging. The NeuSight PET-CT's patient-centered design, advanced technology, and versatility in molecular imaging applications make it an ideal solution for healthcare providers seeking enhanced diagnostic accuracy and improved patient outcomes. This strategic move is expected to have a positive impact on Positron's financial projections and solidify its position in the nuclear imaging market.